Matija Snuderl

NYU Langone Health

Full Professor(heuristic)

Glioma Diagnosis and Treatment · Genetics

h-index75

i10-index206

Publications718

Citations26,961

Grants

8 total · 4 active

NIH #5R01NS122987-04

Inducing Neural Maturation in Medulloblastoma by Targeting EZH2

Expiring Soon

Amount: $687K
Period: 2022-09-15 → 2026-08-31
PIs: 2
Est. capacity / PI: ~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #5R01NS122987-03

Inducing Neural Maturation in Medulloblastoma by Targeting EZH2

Expiring Soon

Amount: $672K
Period: 2022-09-15 → 2026-08-31
PIs: 2
Est. capacity / PI: ~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #5R01NS122987-02

Inducing neural maturation in medulloblastoma by targeting EZH2

Expiring Soon

Amount: $700K
Period: 2022-09-15 → 2026-08-31
PIs: 2
Est. capacity / PI: ~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

Lab Funding Health

Find elsewhere

Institution / lab homepage Search on ResearchGate

In-Field Influence

0.0186

PageRank within Genetics co-authorship network

Explore collaboration map

Admission Signals

New paper: Papillary Renal Neoplasm With Reverse Polarity Is a Distinct Distal Nephron-Derived Tumor With Unique Methylation Profile (The American Journal of Surgical Pathology)2026-06-16
New NIH award: $687K — Inducing Neural Maturation in Medulloblastoma by Targeting EZH22022-09-15
New NIH award: $672K — Inducing Neural Maturation in Medulloblastoma by Targeting EZH22022-09-15
New NIH award: $700K — Inducing neural maturation in medulloblastoma by targeting EZH22022-09-15
New NIH award: $743K — Inducing neural maturation in medulloblastoma by targeting EZH22022-09-15

Data Freshness

Publications as of 2026-07-01
Grants as of 2026-06-30

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

ORCID: 0000-0003-0752-0917

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 107

Papillary Renal Neoplasm With Reverse Polarity Is a Distinct Distal Nephron-Derived Tumor With Unique Methylation Profile
The American Journal of Surgical Pathology · 2026-06-16
Salivary Gland Carcinoma with DLG1::BRAF Gene Fusion: Report of a Case
Head and Neck Pathology · 2026-06-09
Previously unrecognised gene fusions across diverse solid tumours identified by anchored multiplex RNA sequencing
Journal of Clinical Pathology · 2026-05-14
Abstract 6521: Actionable fusions and rearrangements can be efficiently identified by Hi-C whole genome sequencing in lung tumors
Cancer Research · 2026-04-03
AI-driven label-free Raman spectromics for intraoperative spinal tumor assessment
npj Digital Medicine · 2026-03-17
1204 Rosai-Dorfman Disease: Report on Clinical and Molecular Features from a Single Large Academic Medical Center
Laboratory Investigation · 2026-03-01
Supplementary Tables S1 and S2 from Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA
2025-12-11
Supplementary Figures 1-15 from Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA
2025-12-11
Detection of targetable genetic alterations in SMARCA4-deficient neoplasms of the lung – further evidence of a relationship between SMARCA4-deficient undifferentiated tumor and non-small cell carcinoma
Human Pathology · 2025-12-05
A developmentally regulated long-range enhancer-promoter contact mediates human neural development
bioRxiv (Cold Spring Harbor Laboratory) · 2025-12-03
DNA Methylation Profiling Classifies and Reveals Origin of Gynecologic Central Nervous System-Like Tumors
Modern Pathology · 2025-11-22 · 1 citations
A Clinical Tool to Identify Incidental Meningioma for Early Outpatient Management
JAMA Oncology · 2025-11-20
A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma
Neuro-Oncology · 2025-11-15 · 1 citations
MRI-based prediction of DNA methylation grade in IDH-mutant astrocytomas using qualitative imaging features and tumor volumetrics
Neuroradiology · 2025-11-11
PATH-75. Hetairos enables AI-based histopathological classification of CNS tumours
Neuro-Oncology · 2025-11-01
PATH-42. Histo-molecular and survival study of high-grade astrocytoma with piloid features
Neuro-Oncology · 2025-11-01
IMG-123. Tumor volume at diagnosis predicts survival in IDH-mutant astrocytomas
Neuro-Oncology · 2025-11-01
IMG-72. [68Ga]Ga-DOTA-TATE PET as imaging biomarker for response assessment and monitoring in patients receiving [177Lu]Lu-DOTA-TATE for advanced intracranial meningioma
Neuro-Oncology · 2025-11-01
CTNI-41. RESULTS OF A SINGLE-ARM, OPEN-LABEL, MULTICENTER PHASE 2 STUDY OF THE RADIOPHARMACEUTICAL [177LU]LU-DOTA-TATE IN ADULTS WITH ADVANCED INTRACRANIAL MENINGIOMA
Neuro-Oncology · 2025-11-01 · 1 citations
DISP-13. DNA methylation-based ethnicity prediction enables analysis of racial disparities in molecularly classified CNS tumors
Neuro-Oncology · 2025-11-01

Open author page on OpenAlex →